A cingulotomy is a brain surgery that creates a small, targeted lesion in the anterior cingulate cortex, a region deep in the brain involved in processing emotions and pain. It is considered a last-resort treatment for people with severe obsessive-compulsive disorder (OCD) or chronic pain that has not responded to any other therapy. The procedure is rare, highly specialized, and only performed after all conventional treatments have failed.
What the Surgery Targets
The anterior cingulate cortex sits along the inner surface of both brain hemispheres, roughly in the middle of the head. This area acts as a hub connecting emotional processing, decision-making, and the experience of pain. In people with treatment-resistant OCD, this region often shows abnormal activity patterns. In chronic pain patients, it plays a central role in how suffering is perceived, separate from the physical sensation of pain itself.
By creating a lesion in this area, the surgery disrupts the circuits that drive uncontrollable obsessive thoughts or amplify the emotional dimension of chronic pain. It does not eliminate the ability to feel pain entirely. Instead, it reduces the distress and psychological weight that pain carries.
How the Procedure Works
Cingulotomy is performed using stereotactic techniques, meaning the surgeon uses MRI scans and a precision frame to map the exact coordinates of the target before making any incision. On the day of surgery, one small burr hole is drilled on each side of the skull. Thin electrodes are then guided through the brain tissue into the anterior cingulate cortex on both sides.
Once the electrodes are in position, heat (radiofrequency energy) is used to create a controlled lesion at the tip. Surgeons typically make three consecutive lesions along each electrode path, spaced about 7 millimeters apart, to account for the natural curve of the cingulate gyrus. The resulting lesion measures roughly 2.5 centimeters long and about 1 centimeter wide on each side. The entire process is guided by imaging to avoid damaging surrounding brain tissue.
Newer approaches are also being explored. MRI-guided laser ablation uses a thin fiber-optic probe to heat the target tissue, with real-time temperature monitoring. Focused ultrasound, which requires no incision at all, is being studied for related procedures, though it is not yet standard for cingulotomy specifically.
Who Is Eligible
Cingulotomy is not offered as an early treatment option. It is reserved for patients who have exhausted all standard therapies. For OCD, this typically means years of medication trials across multiple drug classes, intensive cognitive behavioral therapy, and sometimes other interventions like deep brain stimulation, all without adequate improvement. For chronic pain, candidates have usually cycled through medications, nerve blocks, physical therapy, and other surgical options without lasting relief.
The procedure has been used for cancer-related pain that is severe and unresponsive to opioids, for central poststroke pain (a particularly difficult condition where the brain generates pain signals after a stroke), and for other chronic pain syndromes of non-cancer origin. In some documented cases, it has been offered to patients who had no remaining treatment options at all.
Success Rates for OCD
Long-term response rates for cingulotomy in treatment-resistant OCD range from 32% to 70%, depending on the study and how “response” is defined. In the most rigorous prospective study tracking 44 patients, 32% met full criteria for treatment response at an average follow-up of 32 months, and an additional 14% were partial responders. That means about 45% of patients who had failed every other available treatment experienced at least some meaningful improvement.
Response is typically measured by a 35% or greater improvement on standardized OCD symptom scales, sustained for at least six months. One important detail: improvement is sometimes delayed. Some patients show little change in the first weeks or months, then gradually improve. This delayed effect has been observed often enough that researchers consider it a genuine feature of the procedure rather than a placebo response.
Success Rates for Chronic Pain
Pain relief outcomes are broadly encouraging but variable. Across 224 patients in a systematic review, over 60% achieved significant pain relief immediately after surgery, and that benefit persisted at one year for many. Among patients followed for at least 12 months, 65% still reported meaningful relief, including both cancer and non-cancer pain patients.
For cancer-related pain specifically, about 67% of patients reported significant relief at one month. That number declined over time to 58% at three months and 50% at six months, partly because the underlying disease progresses. For non-cancer chronic pain, the results were comparable: 65% of patients with at least three months of follow-up reported significant relief. Some patients saw opioid use drop by as much as 80% after the procedure.
The overall range of reported efficacy across all pain studies is 32% to 83%, reflecting differences in patient populations, pain types, and how aggressively success is defined. Some patients who initially fail the procedure undergo a repeat cingulotomy and achieve relief the second time.
Side Effects and Cognitive Impact
One of the most common concerns people have about any brain surgery targeting behavior or emotions is whether it changes personality or thinking ability. The evidence on cingulotomy is reassuring on this point. Studies consistently fail to find significant cognitive dysfunction after the procedure. Language, memory, motor skills, visual-spatial abilities, and overall intellectual function all remain intact in outcome assessments.
The one exception is focused attention, which can decline in the early postoperative period. This tends to be temporary rather than permanent. The complication rate across radiofrequency-based procedures is about 16%, though the vast majority of those complications (around 15 out of that 16%) are mild neurological or behavioral changes that do not require additional hospitalization. Roughly 1.4% of patients experience acute complications serious enough to extend their hospital stay.
Seizures are a potential risk with any procedure that creates a brain lesion, and headaches after surgery are common but typically short-lived. The procedure does not produce the dramatic personality changes historically associated with older, cruder forms of psychosurgery like the frontal lobotomy. Cingulotomy targets a much smaller, more precisely defined area.
How It Differs From Other Procedures
Cingulotomy is one of several neurosurgical options for treatment-resistant psychiatric conditions, and the differences matter. A capsulotomy targets a different brain structure (the internal capsule) and has shown marginally higher efficacy for OCD in pooled analyses, though it comes with a similar risk profile. Deep brain stimulation uses implanted electrodes to modulate brain activity without destroying tissue, making it reversible but requiring ongoing hardware maintenance and battery replacements.
Compared to capsulotomy and deep brain stimulation, cingulotomy has a long track record and a relatively straightforward surgical approach. It does not require permanent implants. However, because it creates a permanent lesion, the effects cannot be undone. This is why the procedure is reserved for cases where the severity of the condition clearly outweighs the irreversibility of the intervention.